SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Propanc Biopharma, Inc. PPCB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • AU • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Propanc Biopharma, Inc. (PPCB) 有 11 个已识别的同行可供比较在 Healthcare 板块. 同行包括 AVRO, CVAC, CWBR, ELEV, ENVB, HEPA 等.

PPCB 的市值为 $1.48M, 而同行平均市值为 $1.59B. PPCB 显著小于其平均同行.

同行与相似公司 — PPCB

$1.40 -1.41% $5.24M

$4.66 0.00% $1.05B

$0.41 0.00% $1.19M

Elevation Oncology, Inc.

$0.37 -2.12% $21.63M

Enveric Biosciences, Inc.

$1.95 -1.02% $1.16M

Hepion Pharmaceuticals, Inc.

$0.05 +18.52% $557.78K

Krystal Biotech, Inc.

$270.00 +0.97% $7.89B

Ocean Biomedical, Inc.

Reata Pharmaceuticals, Inc.

$172.36 +0.02% $6.57B

Vir Biotechnology, Inc.

$10.05 +7.95% $1.61B

Zura Bio Limited

$5.72 +0.70% $371.93M

其他人也在看

Krystal Biotech, Inc.

Reata Pharmaceuticals, Inc.

Vir Biotechnology, Inc.

Zura Bio Limited

Elevation Oncology, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言